Compare IOT & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOT | HOLX |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5B | 16.9B |
| IPO Year | 2021 | 1995 |
| Metric | IOT | HOLX |
|---|---|---|
| Price | $32.15 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 13 |
| Target Price | $45.42 | ★ $77.89 |
| AVG Volume (30 Days) | 6.4M | ★ 95.4M |
| Earning Date | 06-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.86 | N/A |
| EPS | 0.08 | ★ 0.79 |
| Revenue | $1,618,635,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $23.00 | $4.74 |
| Revenue Next Year | $19.69 | $5.03 |
| P/E Ratio | $408.00 | ★ $96.23 |
| Revenue Growth | ★ 29.57 | 1.74 |
| 52 Week Low | $23.38 | $63.19 |
| 52 Week High | $47.47 | $76.07 |
| Indicator | IOT | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 48.97 | 69.09 |
| Support Level | $31.17 | $75.10 |
| Resistance Level | $32.17 | N/A |
| Average True Range (ATR) | 2.19 | 0.19 |
| MACD | -0.19 | 0.03 |
| Stochastic Oscillator | 30.46 | 95.19 |
Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers range from small and medium-sized businesses to state and local governments.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.